81 FR 71515 - National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 81, Issue 200 (October 17, 2016)
National Institutes of Health
Federal Register Volume 81, Issue 200 (October 17, 2016)
| Page Range | 71515-71515 | |
| FR Document | 2016-25069 |
[Federal Register Volume 81, Number 200 (Monday, October 17, 2016)] [Notices] [Page 71515] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-25069] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel; NIAMS Clinical Study Applications. Date: October 19, 2016. Time: 10:30 a.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Kan Ma, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute of Arthritis, Musculoskeletal and Skin Diseases, NIH, 6701 Democracy Boulevard, Suite 814, Bethesda, MD 20892, 301-451-4838, [email protected]. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Dated: October 12, 2016. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016-25069 Filed 10-14-16; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 81, No. 200 / Monday, October 17, 2016 / Notices 71515
DEPARTMENT OF HEALTH AND include this information at the time of Name of Committee: National Institute of
HUMAN SERVICES registration to ensure that the Arthritis and Musculoskeletal and Skin
appropriate security procedure to gain Diseases Special Emphasis Panel; NIAMS
Advisory Council on Alzheimer’s Clinical Study Applications.
entry to the building is carried out.
Date: October 19, 2016.
Research, Care, and Services; Meeting Although the meeting is open to the Time: 10:30 a.m. to 1:30 p.m.
AGENCY: Assistant Secretary for public, procedures governing security Agenda: To review and evaluate grant
Planning and Evaluation, HHS. and the entrance to federal buildings applications.
may change without notice. If you wish Place: National Institutes of Health,
ACTION: Notice of meeting.
to make a public comment, you must Bethesda, MD 20892 (Telephone Conference
SUMMARY: This notice announces the note that within your email. Call).
Contact Person: Kan Ma, Ph.D., Scientific
public meeting of the Advisory Council SUPPLEMENTARY INFORMATION: Notice of
Review Officer, Scientific Review Branch,
on Alzheimer’s Research, Care, and these meetings is given under the National Institute of Arthritis,
Services (Advisory Council). The Federal Advisory Committee Act (5 Musculoskeletal and Skin Diseases, NIH,
Advisory Council on Alzheimer’s U.S.C. App. 2, section 10(a)(1) and 6701 Democracy Boulevard, Suite 814,
Research, Care, and Services provides (a)(2)). Topics of the Meeting: The Bethesda, MD 20892, 301–451–4838, mak2@
advice on how to prevent or reduce the Advisory Council will hear from a mail.nih.gov.
burden of Alzheimer’s disease and number of CMS’s HCIA awardees about This notice is being published less than 15
related dementias on people with the their projects and their results. days prior to the meeting due to the timing
disease and their caregivers. The theme Additional presentations in the limitations imposed by the review and
of the October meeting will be on racial afternoon will include an overview of funding cycle.
and ethnic disparities in research and the 2016 Update to the National Plan, (Catalogue of Federal Domestic Assistance
care for dementia. Presentations will updates on progress towards a Care and Program Nos. 93.846, Arthritis,
focus on general demographics, gaps Services Summit, and federal Musculoskeletal and Skin Diseases Research,
and barriers that various groups face in National Institutes of Health, HHS)
workgroup updates.
obtaining services, and successful Procedure and Agenda: This meeting Dated: October 12, 2016.
interventions to reduce these gaps. is open to the public. Please allow 45 Sylvia L. Neal,
Additional presentations in the minutes to go through security and walk Program Analyst, Office of Federal Advisory
afternoon will include further to the meeting room. The meeting will Committee Policy.
discussion of the 2016 Update to the also be webcast at www.hhs.gov/live. [FR Doc. 2016–25069 Filed 10–14–16; 8:45 am]
National Plan, updates on progress Authority: 42 U.S.C. 11225; Section 2(e)(3) BILLING CODE 4140–01–P
towards a Care and Services Summit, of the National Alzheimer’s Project Act. The
and federal workgroup updates. panel is governed by provisions of Public
DATES: The meeting will be held on Law 92–463, as amended (5 U.S.C. Appendix DEPARTMENT OF HEALTH AND
October 31st, 2016 from 9:00 am to 5:00 2), which sets forth standards for the HUMAN SERVICES
pm EDT. formation and use of advisory committees.
ADDRESSES: The meeting will be held in Dated: September 30, 2016. National Institutes of Health
Room 800 in the Hubert H. Humphrey Kathryn E. Martin,
National Cancer Institute; Notice of
Building, 200 Independence Avenue Acting Assistant Secretary for Planning and
Closed Meetings
SW., Washington, DC 20201. Evaluation.
Comments: Time is allocated in the [FR Doc. 2016–24971 Filed 10–14–16; 8:45 am] Pursuant to section 10(d) of the
afternoon on the agenda to hear public BILLING CODE P Federal Advisory Committee Act, as
comments. The time for oral comments amended (5 U.S.C. App.), notice is
will be limited to two (2) minutes per hereby given of the following meetings.
individual. In lieu of oral comments, DEPARTMENT OF HEALTH AND The meetings will be closed to the
formal written comments may be HUMAN SERVICES public in accordance with the
submitted for the record to Rohini provisions set forth in sections
Khillan, ASPE, 200 Independence National Institutes of Health 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Avenue SW., Room 424E, Washington, as amended. The grant applications and
DC 20201. All comments should be National Institute of Arthritis and the discussions could disclose
submitted to napa@hhs.gov for the Musculoskeletal and Skin Diseases; confidential trade secrets or commercial
record and to share with the Advisory Notice of Closed Meeting property such as patentable material,
Council by October 25, 2016. Those Pursuant to section 10(d) of the and personal information concerning
submitting comments should identify Federal Advisory Committee Act, as individuals associated with the grant
themselves and any relevant amended (5 U.S.C. App.), notice is applications, the disclosure of which
organizational affiliations. hereby given of the following meeting. would constitute a clearly unwarranted
FOR FURTHER INFORMATION CONTACT: The meeting will be closed to the invasion of personal privacy.
Rohini Khillan (202) 690–5932, public in accordance with the Name of Committee: National Cancer
rohini.khillan@hhs.gov. Note: Seating provisions set forth in sections Institute Special Emphasis Panel; NCI
may be limited. Those wishing to attend 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Clinical and Translational (R21) SEP 4.
the meeting must send an email to as amended. The grant applications and Date: November 7, 2016.
napa@hhs.gov and put ‘‘October 31 the discussions could disclose Time: 12:00 p.m. to 4:30 p.m.
jstallworth on DSK7TPTVN1PROD with NOTICES
Meeting Attendance’’ in the Subject line confidential trade secrets or commercial Agenda: To review and evaluate grant
by Friday, October 21st, 2016 so that property such as patentable material, applications.
Place: National Cancer Institute Shady
their names may be put on a list of and personal information concerning Grove, 9609 Medical Center Drive, Room
expected attendees and forwarded to the individuals associated with the grant 7W606, Rockville, MD 20850, (Telephone
security officers the Humphrey applications, the disclosure of which Conference Call).
Building. Any interested member of the would constitute a clearly unwarranted Contact Person: Timothy C. Meeker, MD,
public who is a non-U.S. citizen should invasion of personal privacy. Ph.D., Scientific Review Officer, Resources
VerDate Sep<11>2014 14:22 Oct 14, 2016 Jkt 241001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\17OCN1.SGM 17OCN1](https://thefederalregister.org/doc/81_FR_71715/page/1.svg)
Document Created: 2016-10-15 01:52:27
Document Modified: 2016-10-15 01:52:27
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | October 19, 2016. | |
| FR Citation | 81 FR 71515 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR